Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.577, 2009-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :
Natalizumab shows clinical, cost and QOL benefits
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. :
Natalizumab knocks out multiple sclerosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. :
Natalizumab knocks out multiple sclerosis
Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. :